Chief Executive Officer ASCO CancerlinQ
Kevin Fitzpatrick joined the American Society of Clinical Oncology (ASCO) in 2015. He previously served as executive vice president and chief innovation officer at the American College of Cardiology (ACC), where he jointly led the organization’s overall financial management and operational and strategic planning. Prior to his work at ACC, He was vice president of business development for Lippincott Williams & Wilkins, managing director of the Duke/Hewlett Packard Center for Outcomes Research, and director of the Trauma Research Laboratory at Duke University Medical Center. Fitzpatrick was instrumental in the creation and implementation of the Diabetes Collaborative Registry™, the first global, cross-specialty clinical diabetes registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum. In addition, he has been very involved in the growth and development of ACC’s PINNACLE Registry®, cardiology’s largest outpatient quality improvement registry, capturing data on coronary artery disease, hypertension, heart failure and atrial fibrillation. In 1996 Fitzpatrick received the Smithsonian Institution/Computer World Healthcare Computing Innovation Award.